Home Cart Sign in  
Chemical Structure| 83004-13-1 Chemical Structure| 83004-13-1

Structure of 83004-13-1

Chemical Structure| 83004-13-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 83004-13-1 ]

CAS No. :83004-13-1
Formula : C7H8BrN
M.W : 186.05
SMILES Code : CCC1=CC=CC(Br)=N1
MDL No. :MFCD11869660
InChI Key :TYOSQEKDQKYBLX-UHFFFAOYSA-N
Pubchem ID :12954800

Safety of [ 83004-13-1 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Computational Chemistry of [ 83004-13-1 ] Show Less

Physicochemical Properties

Num. heavy atoms 9
Num. arom. heavy atoms 6
Fraction Csp3 0.29
Num. rotatable bonds 1
Num. H-bond acceptors 1.0
Num. H-bond donors 0.0
Molar Refractivity 41.71
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

12.89 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

2.18
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

2.71
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.41
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.91
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

2.81
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

2.4

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-3.13
Solubility 0.139 mg/ml ; 0.000744 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.63
Solubility 0.432 mg/ml ; 0.00232 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-3.67
Solubility 0.0398 mg/ml ; 0.000214 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

Yes
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-5.51 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

2.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

1.75

Application In Synthesis of [ 83004-13-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 83004-13-1 ]

[ 83004-13-1 ] Synthesis Path-Downstream   1~23

  • 1
  • [ 5315-25-3 ]
  • [ 74-88-4 ]
  • [ 83004-13-1 ]
YieldReaction ConditionsOperation in experiment
75% Preparation 23 Synthesis of 2-bromo-6-ethyl-pyridine Add under nitrogen a solution of 2.5 M n-butyllithium in hexanes (186.74 mL, 0.467 mol) over 41 min to a solution of diisopropylamine (68.7 mL, 0.488 mol) in tetrahydrofuran (745 mL, 9.16 mol) at -78° C. (dry-ice/acetone bath). Stir for 15 min and add 2-bromo-6-methylpyridine (49.3 mL, 0.424 mol) dropwise over 22 min. Stir 15 min, add methyl iodide (52.87 mL, 0.848 mol) dropwise over 1 hour and then warm to room temperature over 1.5 hour. Add water (250 mL) while cooling with a dry-ice/acetone bath and separate the layers. Extract the aqueous phase twice with ethyl acetate (300 mL). Combine the organic phases, concentrate and purify by silica gel chromatography, gradient eluding from 100:0 to 80:20 using hexanes:ethyl acetate, to give the title compound as a yellow oil (59.74 g, 75percent). 1H NMR (CDCl3) delta 1.28 (t, 3H), 2.80 (q, 2H), 7.11 (d, 1H), 7.27 (d, 1H), 7.45 (t, 1H).
46% To a solution of 2-bromo-6-methylpyridine (CAS 5315-25-3) (2.0 g, 11.7 mmol, 1.0 eq) in THF (10 mL) was added LDA (12.3 mL, 12.3 mmol, 1.05 eq) at -78 °C. After stirring at -78 °C for 1 h, CH3I (1.8 g, 12.3 mmol, 1.05 eq) was added to the mixture. The mixture was stirred at rt for 3 h. The mixture was quenched with sat. NH4C1 (2 mL), diluted with water (50 mL) and extracted with EA (2 x 100 mL). The combined organic phase was washed with brine and dried over Na2S04. After concentration, the residue was purified by silica gel chromatography with PE/EA (20/1) as eluent to give 2-bromo-6-ethylpyridine. 1.0 g, as a yellow solid, Y: 46percent. ESI-MS (M+H)+: 185.9, 187.9.
46% To a solution of 2-bromo-6-methylpyridine (CAS 53 15-25-3) (2.0 g, 11.7 mmol, 1.0 eq) in THF (10 mL) was added LDA (12.3 mL, 12.3 mmol, 1.05 eq) at -78 °C. After stirring at -78°C for 1 h, CH3I (1.8 g, 12.3 mmol, 1.05 eq) was added to the mixture. The mixture was stirred atrt for 3 h. The mixture was quenched with sat. NH4C1 (2 mL), diluted with water (50 mL) and extracted with EA (2 x 100 mL). The combined organic phase was washed with brine and dried over Na2504. After concentration, the residue was purified by silica gel chromatography with PE/EA (20/1) as eluent to give 2-bromo-6-ethylpyridine. 1.0 g, as a yellow solid, Y: 46percent. ESIMS (M+H): 185.9, 187.9.
  • 2
  • [ 75-77-4 ]
  • [ 83004-13-1 ]
  • [ 134435-21-5 ]
  • 3
  • [ 21717-29-3 ]
  • [ 83004-13-1 ]
  • 4
  • [ 544-92-3 ]
  • [ 83004-13-1 ]
  • [ 59146-66-6 ]
  • 5
  • [ 19437-26-4 ]
  • [ 83004-13-1 ]
  • (6-Ethyl-pyridin-2-yl)-di-pyridin-2-yl-methanol [ No CAS ]
  • 6
  • [ 32315-10-9 ]
  • [ 83004-13-1 ]
  • Bis-(6-ethyl-pyridin-2-yl)-methanone [ No CAS ]
  • Tris-(6-ethyl-pyridin-2-yl)-methanol [ No CAS ]
  • 7
  • [ 83004-13-1 ]
  • 2-bromo-6-ethyl-4-nitro-pyridine [ No CAS ]
  • 9
  • [ 83004-13-1 ]
  • 2-(3,4-dihydro-1H-isoquinolin-2-yl)-6-ethyl-pyridin-4-yl-amine [ No CAS ]
  • 10
  • [ 83004-13-1 ]
  • [ 83004-19-7 ]
  • 11
  • [ 83004-13-1 ]
  • [ 521917-53-3 ]
YieldReaction ConditionsOperation in experiment
20.0 g (>100%) With peracetic acid; In acetic acid; b 2-Bromo-6-ethyl-pyridine 1-oxide To a solution of <strong>[83004-13-1]2-bromo-6-ethyl-pyridine</strong> (15.4 g, 82.8 mmol) (S. G. Davies and M. R. Shipton, J. Chem. Soc., Perkin Trans. 1, 1991, 3, 501) in acetic acid (15 ml) was added peracetic acid (26 ml of a 39percent solution) maintaining T<50° C. After complete addition the mixture was stirred at 50° C. for 5 hr and then cooled to room temperature (rt). Crushed ice (40 g) was added and the pH was adjusted to pH 12 with 40percent aqueous KOH solution. After extraction with CHCl3 (6*60 ml) the combined organic phases were dried (Na2CO3) and evaporated to give 20.0 g (>100percent) of the title compound, MS: m/e=201 (M+) as a yellow oil.
20.0 g (>100%) With peracetic acid; potassium hydroxide; In acetic acid; a 2-Bromo-6-ethyl-pyridine 1-oxide To a solution of <strong>[83004-13-1]2-bromo-6-ethyl-pyridine</strong> (15.4 g, 82.8 mmol) (S. G. Davies and M. R. Shipton, J. Chem. Soc., Perkin Trans. 1, 1991, 3, 501) in acetic acid (15 ml) peracetic acid (26 ml of a 39percent) solution) was added maintaining T<50° C. After completed addition the mixture was stirred at 50° C. for 5 hr and then cooled to rt. Crushed ice (40 g) was added and the mixture was made basic (pH 12) using 40percent KOH solution. After extraction with CHCl3 (6*60 ml) the combined organic phases were dried (Na2CO3) and evaporated to give 20.0 g (>100percent) of the title compound, MS: m/e=201 (M+) as a yellow oil.
  • 12
  • [ 74-88-4 ]
  • [ 83004-13-1 ]
YieldReaction ConditionsOperation in experiment
To a solution of 2-bromo-6-methylpyridine (302 mg, 1.76 mmol) an 10 mL THF at -78° C., was added a solution of lithium diisopropylamide (1.8 M in heptane/THF/ethylbenzene, 1.07 mL, 1.93 mmol). The bright orange/red mixture was treated with iodomethane (0.20 mL, 3.2 mmol). The mixture was stirred at -78° C. for 10 min, then was removed from the ice bath and stirred 30 min. The reaction was quenched with sat. NH4Cl, then was diluted with EtOAc. The organic phase was washed with water (2.x.) and brine, dried (Na2SO4) and concentrated. The crude residue was purified by flash chromatography (0 to 20percent EtOAc/hexanes gradient) to afford 157 mg of Intermediate 163.1 as a colorless oil. LCMS (2 min gradient) RT=1.26 min, 186.0 (M+H)+.
  • 13
  • [ 1461-22-9 ]
  • [ 83004-13-1 ]
  • [ 1189746-39-1 ]
YieldReaction ConditionsOperation in experiment
94% Preparation 33 Synthesis of 2-ethyl-6-tributylstannanyl-pyridine Add under nitrogen a solution of tert-butyllithium in pentane (1.5 M, 80.3 mL, 120.5 mmol) dropwise over 1 hour to a cooled solution of <strong>[83004-13-1]2-bromo-6-ethyl-pyridine</strong> (10.19 g, 54.77 mmol) in anhydrous diethyl ether (101.9 mL) at -78° C. at a rate so that the internal reaction temperature does not exceed -75° C. Stir 15 min and add tri-n-butyltin chloride (16.25 mL, 57.51 mmol) dropwise at a rate so that the internal reaction temperature does not exceed -70° C. Warm to room temperature, add water and separate the layers. Extract the aqueous phase once with diethyl ether. Dry the combined organic layers over sodium sulfate, filter and concentrate to give the title compound as a pale yellow liquid (24.05 g, 94percent) that is subsequently used without further purification. 1H NMR (CDCl3) delta 0.88 (t, 9H), 1.09 (m, 6H), 1.32 (m, 9H), 1.56 (m, 6H), 1.57 (m, 6H), 2.80 (q, 2H), 6.95 (m, 1H), 7.17 (d, 1H), 7.38 (t, 1H).
  • 15
  • [ 1276125-68-8 ]
  • [ 83004-13-1 ]
  • [ 1276125-77-9 ]
YieldReaction ConditionsOperation in experiment
37% Step 2:To a solution of LDA (6.6 mmol) in THF (10 mL) at -78° C. was added compound 11-1 (1.12 g, 6 mmol) in THF (4 mL+1 mL rinse). The resulting deep orange solution was stirred at -78° C. for 5 min. Then a solution of iodide 9-1 (2.35 g, 7.2 mmol) in THF (6 mL+2 mL rinse) was added. The reaction mixture was warmed to room temperature overnight, poured into brine and extracted with EtOAc (3.x.). The combined organic layer was dried (Na2SO4), filtered and concentrated. Purification of the residue with flash column chromatography with EtOAc in hexane (1percent to 8percent gradient over 20 min) followed by distillation gave 0.37 g of the desired product 11-2 as an orange oil (37percent yield).1HNMR (CDCl3, 300 Hz): 7.43 (t, J=7.7 Hz, 1H), 7.27 (dd, J=0.9, 7.8 Hz, 1H), 7.06 (dd, J=0.9, 7.5 Hz, 1H), 2.89-2.77 (m, 1H), 1.75-1.64 (m, 1H), 1.62-1.48 (m, 1H), 1.45-1.38 (m 12H), 1.30-1.13 (m, 7H), 1.08 (s, 6H); 13CNMR (CDCl3, 75 Hz): 177.4, 168.6, 141.6, 138.5, 125.3, 120.1, 79.6, 42.6, 41.8, 40.6, 36.8, 28.1, 28.0, 25.2, 25.0, 20.6; MS calcd for C19H31BrNO2 [M+H]+: 386. Found: 386.
  • 16
  • [ 109-04-6 ]
  • [ 74-85-1 ]
  • [ 83004-13-1 ]
  • 17
  • [ 83004-13-1 ]
  • [ 190771-22-3 ]
  • [ 1380072-43-4 ]
  • 18
  • [ 83004-13-1 ]
  • [ 74289-57-9 ]
  • [ 1283601-75-1 ]
YieldReaction ConditionsOperation in experiment
33% 2-Bromo-6-ethylpyridine (18.2 mmol) was dissolved in 40 ml of tetrahydrofuran [THF], and 1.65 M hexane solution of n-butyllithium (19.1 mmol) was added dropwise thereto with cooling with dry ice-ethanol bath and with stirring.Then, the mixed liquid obtained was stirred for 10 minutes to obtain a reaction mixture.To the reaction mixture obtained, chlorobis (3,5-dimethylphenyl) phosphide (16.8 mmol) dissolved in 20 ml of THF was added, and the temperature was brought back to room temperature and the stirring was carried out under room temperature for 3 hours to conduct the reaction.To the solution obtained, a little amount of water was added to quench the reaction, and a saturated aqueous sodium chloride solution was further added thereto.Next, to the solution obtained, ethyl acetate was added to stir and separate, and then, an ethyl acetate phase (an organic phase) was collected by separation.This organic layer was dried over anhydrous magnesium sulfate, and filtrated, and the filtrate obtained was concentrated under reduced pressure.The concentrate obtained was purified twice with silica gel chromatography (developer: hexane/ethyl acetate = 20/1) to obtain 2.07 g of bis(3,5-dimethylphenyl)(6-ethyl-2-pyridyl)phosphine (Yield 33percent).The purity calculated with 1H-NMR analysis was 97percent.1H-NMR (CDCl3, 600 MHz) : 5 7.44 (td, 1H, J=8.2 Hz), 7.03-6.95 (m, 7H), 7.03 (d, 1H, J=8 Hz), 6.83 (d, 1H, J=8 Hz), 2.83 (q, 2H, J=8 Hz), 2.26 (s, 12H), 1.27 (t, 3H, J= 8Hz)
  • 19
  • [ 79762-54-2 ]
  • [ 83004-13-1 ]
  • 6-bromo-2-(6-methylpyridin-2-yl)-2H-indazole [ No CAS ]
  • 6-bromo-1-(6-ethylpyridin-2-yl)-1H-indazole [ No CAS ]
YieldReaction ConditionsOperation in experiment
19%; 26% The preparation of 6-bromo-l-(6-ethylpyridin-2-yl)-lH-indazole was the same as that of 6-bromo-l-(6-methylpyridin-2-yl)-lH-indazole. The mixture of 6-bromo-l-(6- ethylpyridin-2-yl)-lH-indazole and 6-bromo-2-(6-ethylpyridin-2-yl)-2H-indazole was purified by pre-TLC (PE/EA = 10/1) to give 41-02-0002 and 6-bromo-2-(6-ethylpyridin-2- yl)-2H-indazole. Rf value of 6-bromo-l-(6-ethylpyridin-2-yl)-lH-indazole is more than that of 6-bromo-2-(6-ethylpyridin-2-yl)-2H-indazole. 6-bromo-l-(6-ethylpyridin-2-yl)-lH-indazole, 230 mg, as a yellow solid, Y: 26percent. ESI-MS (M+H)+: 302.0, 304.0. 6-bromo-2-(6-ethylpyridin-2-yl)-2H-indazole, 170 mg, as a yellow solid, Y: 19percent. ESI-MS (M+H)+: 302.0, 304.0.
  • 20
  • [ 83004-13-1 ]
  • [ 521917-54-4 ]
  • 21
  • [ 83004-13-1 ]
  • 2-bromo-3-(6-ethyl-2-pyridyl)indene [ No CAS ]
  • 22
  • [ 83004-13-1 ]
  • 2-methyl-3-(6-ethyl-2-pyridyl)indene [ No CAS ]
  • 23
  • [ 83004-13-1 ]
  • [ 83-33-0 ]
  • 3-(6-ethyl-2-pyridyl)indene [ No CAS ]
YieldReaction ConditionsOperation in experiment
45% A solution of 3.0 g (16.1 mmol) of <strong>[83004-13-1]2-bromo-6-ethylpyridine</strong> in25 mL of tetrahydrofuran was added dropwise at 78 C to 6.5 mL (16.1 mmol) of n-BuLi (2.5 M in n-hexane). The resultingreaction mixture was stirred for 45 min at this temperature. Thereafter,2.1 g (16.1 mmol) of 1-indanone dissolved in 25 mL oftetrahydrofuran was added to the stirred solution. After a reactiontime of 2 h between 60 and 78 C, the solution was left at roomtemperature overnight. The reaction was then hydrolyzed with50 mL of saturated ammonium chloride solution. After extractionwith EtOAc (50 mL 3), the combined organic phase was concentrated,and the residue was treated at 0 C with 100 mL of sulfuricacid drop-wisely (85%). The dark red solution was stirred for 2 h atthis temperature and then poured into 150 g of ice water. Theresulting reaction mixture was neutralized with solid sodiumhydroxide and then washed with diethyl ether. Elution withEtOAc/petroleum ether to give 1.60 g (45%) of 3-(6-ethyl-2-pyridyl)indene as a colorless oil. HR-MS (ESI): Calcd for C16H15N +H,222.1283. Found, 222.1282. 1H NMR (400 MHz, CDCl3, ppm): d[8.19 (d, J = 7.6 Hz, 1H), 7.69 (t, J = 8.4 Hz, 1H), 7.54 (t, J = 6.8 Hz,2H), 7.38 (t, J = 7.2 Hz, 1H), 7.29 (t, J = 7.2 Hz, 1H), 7.15 (d,J = 7.6 Hz, 1H), 7.00 (s, 1H) (Py-H, ArH and Cp-H)], 3.57 (s, 2H,Cp-H), 2.96 (q, J = 7.6 Hz, 2H, CH2), 1.43 (t, J = 7.6 Hz, 3H, CH3).13C NMR (100 MHz, CDCl3, ppm): 163.1, 154.4, 144.7, 143.2,136.7, 133.4, 126.2, 124.9, 123.8, 122.3, 120.4, 119.2, 38.3, 31.5,14.0.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 83004-13-1 ]

Bromides

Chemical Structure| 1037223-35-0

A472792 [1037223-35-0]

2-Bromo-6-isopropylpyridine

Similarity: 0.94

Chemical Structure| 195044-14-5

A343414 [195044-14-5]

2-Bromo-6-tert-butylpyridine

Similarity: 0.92

Chemical Structure| 4926-26-5

A236007 [4926-26-5]

2-Bromo-4,6-dimethylpyridine

Similarity: 0.88

Chemical Structure| 5315-25-3

A173929 [5315-25-3]

2-Bromo-6-methylpyridine

Similarity: 0.87

Chemical Structure| 39774-26-0

A207898 [39774-26-0]

2-Bromo-6-phenylpyridine

Similarity: 0.83

Related Parent Nucleus of
[ 83004-13-1 ]

Pyridines

Chemical Structure| 1037223-35-0

A472792 [1037223-35-0]

2-Bromo-6-isopropylpyridine

Similarity: 0.94

Chemical Structure| 195044-14-5

A343414 [195044-14-5]

2-Bromo-6-tert-butylpyridine

Similarity: 0.92

Chemical Structure| 4926-26-5

A236007 [4926-26-5]

2-Bromo-4,6-dimethylpyridine

Similarity: 0.88

Chemical Structure| 5315-25-3

A173929 [5315-25-3]

2-Bromo-6-methylpyridine

Similarity: 0.87

Chemical Structure| 39774-26-0

A207898 [39774-26-0]

2-Bromo-6-phenylpyridine

Similarity: 0.83